Recent Blog Posts
View Post: ANTI-CANCER
2 Dec 2009
Slide 61: MISCELLANEOUS ANTICANCER AGENTS B. Mitoxantrone alkylation of bases acute leukemias & breast cancer cause myelosuppression, GIT effects & cardiac arrythmias. Slide 62: MISCELLANEOUS ANTICANCER AGENTS C. Interferons ...
View Blog: Recent plicks from myplick.com - http://www.myplick.com/
View Post: Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction ...
6 Nov 2009 by Mandelli, Vignetti, Suciu, Stasi, Petti,...
... the use of mitoxantrone or idarubicin instead of daunorubicin enhances the long-term efficacy of chemotherapy. Supported in part by Grants No. 2U10-CA11488-23 through 2U10-CA11488-36 from the National Cancer Institute, Bethesda, MD; ...
View Blog: Journal of Clinical Oncology Current Issue - http://jco.ascopubs.org/
View Post: Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or ...
1 May 2008 by Berthold, DR, Pond, GR, Roessner, M., de...
Purpose: The TAX-327 study randomized 1006 men with metastatic hormone-refractory prostate cancer to receive 3-weekly docetaxel, weekly docetaxel, or mitoxantrone, each with prednisone. Experimental Design: We used the TAX-327 database ...
View Blog: Clinical Cancer Research recent issues - http://clincancerres.aacrjournals.org/
View Post: AAN: Higher-Than-Expected Leukemia Rates Seen with Mitoxantrone in MS
10 Oct 2009 by admin
The study examined records of all patients with multiple sclerosis treated with mitoxantrone since 1999 at the participating hospitals. Inclusion criteria included a minimum of one treatment cycle and one year of follow-up. ...
View Blog: Discuss Cancer - http://discuss-cancer.com/
View Post: Risk Of Leukemia With Multiple Sclerosis Drug Is High
25 Nov 2009 by admin
“It is vital that all MS patients treated with mitoxantrone undergo prolonged and careful hematological follow-up to check for acute leukemia,” Martinelli said. The American Cancer Society has estimated there were 44270 new cases of ...
View Blog: Noah Blog - http://27000article.cn/poah/
View Post: A phase II study of pemetrexed as second-line chemotherapy for the ...
24 Nov 2009 by Hahn, NM, Zon, RT, Yu, M., Ademuyiwa, FO,...
Background: No standard therapy exists for post-docetaxel castrate-resistant prostate cancer (CRPC) patients. This trial aimed to determine the safety and efficacy of pemetrexed in post-docetaxel CRPC patients. Materials and methods: CRPC patients ... Further investigation of pemetrexed as a single agent in a nonenriched CRPC population is unlikely to add significant clinical benefit over that seen with traditional second-line chemotherapy agents such as mitoxantrone. ...
View Blog: Annals of Oncology - recent issues - http://annonc.oxfordjournals.org/
View Post: Multiple sclerosis Diagnosis : Overview Of The Mitoxantrone ...
28 Oct 2009 by Multiple Sclerosis Diagnosis
Multiple sclerosis Diagnosis : Mitoxantrone has been used in the past for prostate cancer and leukemia but latest research proved its immunosuppressant character and thus, its efficiency in dealing with MS. By reducing the activity of ...
View Blog: multiple sclerosis diagnosis symptoms,... - http://multiplesclerosisdiagnosis.net/
View Post: Prostate Cancer – Overall
28 Nov 2009 by admin
The advent of docetaxel (Taxotere ) amended the therapeutic possibilities, Entr'ouvert by mitoxantrone (Novantrone ) some years earlier. For the first time, a drug used in advanced stages of the disease, managed to improve survival and ...
View Blog: Mens Blog - http://mensblog.iblogger.org/
View Post: Canine Cancer News
Prevent pet Cancer Tips
Healthy Pet Care ... ...
View Blog: We traveled to get to an oncologist for treatment and he started mitoxantrone a week ago. They do 5 doses/once every 3 wks. The mitoxantrone caused him to also be down and he still hasn't stopped needed a ridiculous amount of sleep.
View Post: IDARUBICIN MAYBE BETTER FOR AML
23 Oct 2009 by Dr. NICK
Daunorubicin Versus Mitoxantrone Versus Idarubicin as Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10. Mandelli F, Vignetti M, Suciu S, Stasi R, Petti MC, ...
View Blog: CANCER AND IMPORTANT MEDICAL NEWS - http://cancerology.blogspot.com/

Not Signed In -

